Zobrazeno 1 - 10
of 222
pro vyhledávání: '"Eugene, Kotlyar"'
Autor:
Sara Louise Hungerford, Katherine Kearney, Christina Li, Ning Song, Kay Everett, Gaurav Gulati, Nicholas Olsen, Edmund Lau, Andrew Jabbour, Nicole Bart, Eugene Kotlyar, David Muller, Christopher Hayward, Navin Kapur, Audrey Adji
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 23 (2024)
Background The association between raised pulmonary artery pressures, pulmonary vascular resistance (PVR), and right‐sided heart dysfunction is well recognized. The added value of pulsatile indices, specifically pulmonary arterial compliance (PAC)
Externí odkaz:
https://doaj.org/article/d2a4db279493429ba9b29cc03b7624e5
Autor:
Lisa M. Raven, MBBS, FRACP, Christopher A. Muir, MBBS (Hons), FRACP, PhD, Ricardo C. Deveza, MD, FRACP, Cassia Kessler Iglesias, MD (Hons), FRACP, Nicole K. Bart, MBBS (Hons), BSc (Med Sci), DPhil (Oxon), FRACP, Kavitha Muthiah, MBChB, PhD, FRACP, Eugene Kotlyar, MBBS, MD, MPVD, FRACP, Christopher S. Hayward, BMedSc, MBBS (Hons), MD, FRACP, Peter S. Macdonald, MBBS, MD, PhD, FRACP, Andrew Jabbour, BSc (Med), MBBS (Hons), PhD, FRACP, Jerry R. Greenfield, MBBS (Hons 1), PhD, FRACP
Publikováno v:
JHLT Open, Vol 5, Iss , Pp 100088- (2024)
Sodium glucose cotransporter 2 inhibitors (SGLT2i) are an established treatment for heart failure and type 2 diabetes. Guidelines suggest withholding SGLT2i preoperatively due to the risk of ketoacidosis. Orthotopic heart transplantation (OHT) occurs
Externí odkaz:
https://doaj.org/article/ae339804c9d74037960ef486605beb42
Autor:
Nicole Bart, Sara Hungerford, Sam Emmanuel, Eugene Kotlyar, Anne Keogh, Peter MacDonald, David Muller, Christopher Hayward
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 1980-1986 (2023)
Abstract Aims The pulmonary artery pulsatility index (PAPi) is a novel haemodynamic marker that has previously been shown to predict right ventricular dysfunction and mortality in patients with pulmonary hypertension and advanced heart failure. Utili
Externí odkaz:
https://doaj.org/article/19e4071a333c45cca4f1acd88af28619
Autor:
Sara Louise Hungerford, Katherine Kearney, Ning Song, Nicole Bart, Eugene Kotlyar, Edmund Lau, Andrew Jabbour, Christopher Simon Hayward, David William Marshall Muller, Audrey Adji
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 1811-1821 (2023)
Abstract Background The effect of pulmonary hypertension (PH) on right ventricular (RV) afterload is commonly defined by elevation of pulmonary artery (PA) pressure or pulmonary vascular resistance (PVR). In humans however, one‐third to half of the
Externí odkaz:
https://doaj.org/article/14fc30e3453846ea84d17fee0235f005
Autor:
Sara Hungerford, Katherine Kearney, Ning Song, Eugene Kotlyar, Nicole K. Bart, Edmund Lau, Andrew Jabbour, Christopher Simon Hayward, David William Marshall Muller, Audrey Adji
Publikováno v:
Physiological Reports, Vol 11, Iss 7, Pp n/a-n/a (2023)
Abstract It is of increasing importance to understand and predict changes to the systemic and pulmonary circulations in pulmonary hypertension (PH). To do so, it is necessary to describe the circulation in complete quantitative terms. Characteristic
Externí odkaz:
https://doaj.org/article/c2a3a5526c794a2f9017a4f68d0527d7
Autor:
Kavitha Muthiah, Jerry R Greenfield, Nicole K Bart, Peter MacDonald, Eugene Kotlyar, Christopher S Hayward, Andrew Jabbour, Lisa Mary Raven, Christopher A Muir, Cassia Kessler Iglesias
Publikováno v:
BMJ Open, Vol 13, Iss 3 (2023)
Introduction Cardiac transplantation (CTx) is a life-saving operation that can improve the quality and length of a recipient’s life. Immunosuppression medication, required to prevent rejection, can result in adverse metabolic and renal effects. Cli
Externí odkaz:
https://doaj.org/article/085437b45468456e906902249774d07a
Autor:
Karen S. W. Chia, Christine T. Shiner, Karen Brown, Cameron J. Holloway, Camila Moreyra, Nicole Bart, Peter K. K. Wong, Steven G. Faux, Eugene Kotlyar
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 2, Pp n/a-n/a (2022)
Abstract Pulmonary hypertension (PH) is characterized by progressive dyspnea, fatigue, and reduced exercise capacity. Despite medical treatment, outcomes remain poor. While exercise training is well established in patients with heart failure, it is l
Externí odkaz:
https://doaj.org/article/c5e8d2cda8c842e58b92e905f96f7b1d
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/b424d287226f4f0a866741bb51a7c62c
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Background: In a long-term event-driven trial, macitentan has demonstrated beneficial time to clinical worsening in patients with pulmonary arterial hypertension (PAH) and reduced PAH-related hospitalization rates compared with placebo. Macitentan is
Externí odkaz:
https://doaj.org/article/4dfdf290aa9d4e07b131b78760fe2b46
Autor:
Nicole K. Bart, Sara L. Hungerford, Mayooran Namasivayam, Emily Granger, Mark Conellan, Eugene Kotlyar, Kavitha Muthiah, Andrew Jabbour, Christopher Hayward, Paul C. Jansz, Anne M. Keogh, Peter S. Macdonald
Publikováno v:
Transplantation. 107:1390-1397
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d27c6889783cbb7e3681302823d617d
https://doi.org/10.1097/tp.0000000000004511
https://doi.org/10.1097/tp.0000000000004511